Clinical trial
Randomized Multicenter Comparison Between Ultrathin-strut Biodegradable Polymer Sirolimuseluting Stents and Durable Polymer Everolimus-eluting Stents for Patients With Acute ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
NCT05484310 is registered in ClinicalTrials.gov with University Hospital, Geneva as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Multicenter Comparison Between Ultrathin-strut Biodegradable Polymer Sirolimuseluting Stents and Durable Polymer Everolimus-eluting Stents for Patients With Acute ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
- Lead sponsor
- University Hospital, Geneva
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 15, 2021
- Completion date
- October 28, 2023
- Enrollment
- 1,300 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.